Spots Global Cancer Trial Database for Chloroquine for Glioblastoma.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Chloroquine for Glioblastoma.
Official Title: Adjuvant Chloroquine to the Conventional Treatment for Glioblastoma.
Study ID: NCT04772846
Conditions
Glioblastoma
Study Description
Brief Summary: Adjuvant chloroquine to the conventional treatment for glioblastoma; A randomized, single-blind, placebo-controlled, phase I/II trial.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Private clinics, Cairo, , Egypt
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
